文献速递毛发、甲与色素性疾病

美国不同种族、年龄和性别白癜风诊断的发病率与患病率

Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US.
PubMed 文献 · JAMA Dermatol · 2023-01-01

结果显示,年龄和性别调整后的总体发病率为22.6/10万人年(95%CI 21.5-23.8),患病率为0.16%(95%CI 0.15%-0.17%);发病率和患病率在老年、西班牙裔/拉丁裔及亚裔美国人患者中较高。

要点

  • 年龄和性别调整后总体发病率为22.6/10万人年,患病率为0.16%。
  • 发病率最高年龄组为60-69岁,患病率最高年龄组为70岁及以上。
  • 年龄调整后发病率最高为亚裔美国人,患病率最高为西班牙裔/拉丁裔。

核心结论

  • 该横断面研究发现,白癜风诊断在老年患者、西班牙裔/拉丁裔患者和亚裔美国人患者中更为常见。

研究设计与样本

  • 队列研究和横断面研究分析,纳入美国4个普查区域寻求医疗服务的儿童、青少年和成人的电子健康记录,发病率分析数据来自2015年1月1日至2019年12月31日,患病率分析数据来自2019年1月1日至12月31日。

主要发现

  • 发病率分析纳入2 980 778例白癜风患者,平均(SD)年龄41.5(24.0)岁,57.0%为女性;患病率分析纳入1 057 534例,平均(SD)年龄43.4(24.7)岁,57.5%为女性。
  • 年龄和性别调整后总体发病率为22.6/10万人年(95%CI 21.5-23.8),患病率为0.16%(95%CI 0.15%-0.17%)。
  • 性别调整后发病率最高为60-69岁患者(25.3/10万人年;95%CI 22.2-28.6),患病率最高为70岁及以上患者(0.21%;95%CI 0.19%-0.23%)。
  • 年龄调整后发病率最高为亚裔美国人(41.2/10万人年;95%CI 28.2-58.2),其次为西班牙裔/拉丁裔(37.3/10万人年;95%CI 25.7-52.4)、其他或多个种族(31.1/10万人年;95%CI 25.9-37.1)、黑人(29.6/10万人年;95%CI 26.0-33.6)和白人(18.7/10万人年;95%CI 17.5-20.0)。
  • 年龄调整后患病率最高为西班牙裔/拉丁裔(0.29%;95%CI 0.20%-0.39%),其次为亚裔美国人(0.27%;95%CI 0.19%-0.35%)、其他或多个种族(0.24%;95%CI 0.20%-0.28%)、黑人(0.22%;95%CI 0.19%-0.24%)和白人(0.13%;95%CI 0.12%-0.14%)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Vitiligo has substantial psychosocial consequences. Yet its burden is poorly established. OBJECTIVE: To estimate incidence and prevalence of diagnosed vitiligo across age, sex, and racial and ethnic subgroups in the US. DESIGN, SETTING, AND PARTICIPANTS: This analysis comprising a cohort study and cross-sectional study included electronic health records for health care-seeking children, adolescents, and adults across 4 US census regions. Data for the incidence analysis were obtained from January 1, 2015, through December 31, 2019, and data for the prevalence analysis were obtained from January 1 through December 31, 2019. Data were analyzed from December 13, 2022, to June 8, 2023. MAIN OUTCOMES AND MEASURES: The main outcomes were incidence (per 100 000 person-years [PY]) and prevalence of diagnosed vitiligo overall and by age, race and ethnicity, and sex. RESULTS: A total of 2 980 778 patients with vitiligo were included in the incidence analysis (mean [SD] age, 41.5 [24.0] years; 57.0% female; 1.4% Asian American; 12.9% Black; 1.5% Hispanic/Latino; 77.3% White; 6.9% other or multiracial) and 1 057 534 in the prevalence analysis (mean [SD] age, 43.4 [24.7] years; 57.5% female; 1.7% Asian American, 14.7% Black, 1.4% Hispanic/Latino; 75.7% White; 6.6% other or multiracial). Age- and sex-adjusted overall incidence rate (IR) of diagnosed vitiligo was 22.6 per 100 000 PY (95% CI, 21.5-23.8 per 100 000 PY), and prevalence was 0.16% (95% CI, 0.15%-0.17%). Sex-adjusted IR was highest among patients aged 60 to 69 years (25.3 per 100 000 PY; 95% CI, 22.2-28.6 per 100 000 PY), and prevalence was highest among patients aged 70 years or older (0.21%; 95% CI, 0.19%-0.23%). The highest age-adjusted IR was observed among Asian American patients (41.2 per 100 000 PY; 95% CI, 28.2-58.2 per 100 000 PY), followed by Hispanic/Latino patients (37.3 per 100 000 PY; 95% CI, 25.7-52.4 per 100 000 PY), patients reporting other or multiple races (31.1 per 100 000 PY; 95% CI, 25.9-37.1 per 100 000 PY), Black patients (29.6 per 100 000 PY; 95% CI, 26.0-33.6 per 100 000 PY), and White patients (18.7 per 100 000 PY; 95% CI, 17.5-20.0 per 100 000 PY). The highest age-adjusted prevalence was observed among Hispanic/Latino patients (0.29%; 95% CI, 0.20%-0.39%), followed by Asian American patients (0.27%; 95% CI, 0.19%-0.35%), patients reporting other or multiple races (0.24%; 95% CI, 0.20%-0.28%), Black patients (0.22%; 95% CI, 0.19%-0.24%), and White patients (0.13%; 95% CI, 0.12%-0.14%). CONCLUSIONS AND RELEVANCE: This cross-sectional study found that vitiligo diagnosis was more common in older patients, Hispanic/Latino patients, and Asian American patients.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Mastacouris N, Strunk A, Garg A, et al. Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US. JAMA Dermatol. 2023. PMID: 37466934. doi:10.1001/jamadermatol.2023.2162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。